Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Operating Expenses | 10,792 | 30,483 | 12,970 | 9,151 | 7,222 |
| Operating Income | -10,792 | -30,483 | -12,970 | -9,151 | -7,222 |
| Other Income | 19 | 42 | 83 | 20 | 2,603 |
| Pre-tax Income | -10,773 | -30,441 | -12,887 | -9,131 | -4,619 |
| Income Tax | N/A | -6,908 | N/A | N/A | N/A |
| Net Income Continuous | -10,773 | -23,533 | -12,887 | -9,131 | -4,619 |
| Net Income | $-10,773 | $-23,533 | $-12,887 | $-9,131 | $-4,619 |
| EPS Basic Total Ops | -0.52 | -1.57 | -0.81 | -0.58 | -0.30 |
| EPS Basic Continuous Ops | -0.48 | -1.47 | -0.81 | -0.58 | -0.29 |
| EPS Diluted Total Ops | -0.52 | -1.57 | -0.81 | -0.58 | -0.30 |
| EPS Diluted Continuous Ops | -0.48 | -1.47 | -0.81 | -0.58 | -0.29 |
| EPS Diluted Before Non-Recurring Items | -0.54 | -0.36 | -0.84 | N/A | N/A |
| EBITDA(a) | $-10,534 | $-30,308 | $-12,781 | $-8,963 | $-6,992 |